You are here

Re: First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial. K. O. Kagan, R. Sroka, J. Sonek, H. Abele, K. Lüthgens, M. Schmid, P. Wagner, S. Brucker, D. Wallwiener and M. Hoopmann. Ultrasound Obstet Gynecol 2018; 51: 437-444.

Pubmed ID: 
29634092
Year: 
2018
Month: 
04
Volume: 
51
Issue: 
4
Citation: 
Hui L. Re: First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial. K. O. Kagan, R. Sroka, J. Sonek, H. Abele, K. Lüthgens, M. Schmid, P. Wagner, S. Brucker, D. Wallwiener and M. Hoopmann. Ultrasound Obstet Gynecol 2018; 51: 437-444. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 51 (4) : 436(2018) PubMed